Victoria Alday-Sanz, D.V.M., M.Sc., Ph.D. Member of the OIE ad hoc group on Antimicrobials in Aquatic Animals
|
|
- Elvin Lamb
- 5 years ago
- Views:
Transcription
1
2 Victoria Alday-Sanz, D.V.M., M.Sc., Ph.D. Member of the OIE ad hoc group on Antimicrobials in Aquatic Animals
3 Peter Smith, Chair (Academician) Jennifer Matysczak (FDA) Donald Prater (FDA) Gerard Moulin (National Agency for Veterinary Medicinal Products, France) Celia Pitogo (Aquaculture producer, Phillipines/Brunei) Victoria Alday (Aquaculture producer) OIE Staff
4 Chapter 6.3. Principles for responsible and prudent use of antimicrobial agents in aquatic animals Chapter 6.4. Monitoring of the quantities and usage patterns of antimicrobial agents used in aquatic animals Chapter 6.5. Development and harmonisation of national antimicrobial resistance surveillance and monitoring programmes for aquatic animals
5 It defines the responsabilities of: The Competent Authorities The veterinary pharmaceutical industry The wholesale and retail distributor The veterinarians and other aquatic animal health professionals The aquatic animal producers
6 Responsabilities of the Competent Authorities (1) Specifying the terms of the authorization and providing the appropriate information through labeling or other means Developing up-to-date guidelines on data requirements for evaluation of antimicrobial agent applications Promoting good animal husbandry practices, vaccination policies and development of animal health care at the farm level, together with veterinarians (p/v) Granting marketing authorizations when criteria of quality, efficacy and safety are met.
7 Monitor the performance of susceptibility testing from laboratories and disseminating information on trends in antimicrobial resistance collected during surveillance programmes to veterinarians (p/v) and should. Providing effective procedures for the safe collection and destruction of unused or out-of-date antimicrobial agents.
8 Responsabilities of the veterinary pharmaceutical industry Providing information requested by the CA: on the quality, efficacy and safety of antimicrobial agents Covering pre- and post- marketing phases, including manufacturing, sale, importation, labelling, advertising and pharmacovigilance. amount of antimicrobial agents marketed. Should ensure that the advertising antimicrobial agents to the aquatic animal producer is discouraged.
9 Compliance with the relevant legislation Availability of information for the appropriate use and disposal with each distributed product Maintaining and disposing of the product according to the manufacturer recommendations.
10 Responsabilities of the veterinarians and other aquatic animal health professionals (1) Promote biosecurity programs to minimise the need for antimicrobial use Only prescribe, dispense or administer antimicrobials for aquatic animals under their care Reach a diagnosis before prescription and analyse environmental conditions for primary cause If treatment is deemed necessary it should be initiated as soon as possible and only later confirm susceptibility of the agent Results of all susceptibility tests should be available to the CA
11 Indicating the treatment regime: dose, duration, withdrawal period and amount to be delivered Using of extra-label/off-label in conformity with the legislation. Revise farm records to ensure compliance with their directions and evaluate the efficacy of treatment Records on the use should be kept and lack of efficacy should be reported to the CA
12 Implementing biosecurity programmes: culture strategies, vaccination, pathogen detection, maintenance of good water, etc Using antimicrobials only on the prescription of a veterinarian (p/v) and following his/her directions Properly storaged, handling and disposal Keeping records of antimicrobial agents used, bacteriological and susceptibility tests and make such records available to the veterinarian (p/v) Informing of recurrent disease problems and lack of efficacy of antimicrobial agent treatment regimes.
13 This information is crucial to carry out: Risk analysis: identification of trends in the use and the association with resistance Risk management: evaluating the effectiveness of use and mitigation strategies Development of an standard monitoring system (human, agriculture and aquaculture): quantities, class, route, diagnosis Should include related data to interpreter the use of antimicrobial agents (system, developmental stage, culture parameters, dosage, duration, etc )
14 Establish data on the prevalence of resistance Collect information on antimicrobial resistance trends Explore relationship resistance in aquatic animal microorganisms and the use of antimicrobial agents; Detect the emergence of antimicrobial resistance mechanisms; Provide recommendations on human health and aquatic animal health policies and programmes Etc
15 For microorganisms that infect aquatic animals For microorganisms in or on aquatic animal products intended for human consumption
16 Selection of microorganism: primary pathogen, commonly encountered, not from same epizootic Method: MIC or disc diffusion (standard methods if available: CSLI) Laboratory quality control Choice of all major antimicrobial groups Data publication Interpretation both for epidemiological and clinical purposes
17 Chapter 6.7 of the OIE Terrestrial Animal Health Code Intestinal microflora should only be considered when there is evidence that these are resident for long enough (mostly transient) All sources of contamination should be taken into account (manure or molasses) Minimum species: Salmonella spp.; Vibrio parahaemolyticus; Listeria monocytogenes
18 Victoria Alday-Sanz, D.V.M., M.Sc., Ph.D. Director for Aquatic Animal Health, PESCANOVA Tecnical Advisor for the National Prawn Company
19 Never faced a clinical antimicrobial resistance problem in aquaculture production Antibiotics in aquaculture are tools for very specific situations: Development of culture procedures for new species Primary pathogens (intracelllular bacteria)
20 Diversity
21 Shrimp production Backyard hatchery Industrial scale
22
23 Countries in the early stages of commercial aquaculture (Africa), are putting aquaculture development at the tope of their agendas (key player) for food and job security
24
25 Lack of knowledge on aquaculture, except in Asia Differences in legislation Huge differences in enforcement Shortage of tools for sanitary management: antibiotics, desinfectans, pesticides, etc (contrast with veterinary and human medicine) Insufficient Market Authorizations: expensive process Aquaculture small market: does not justify the investment Many species, many diseases, many culture conditions
26 OTC most used treatment Species % Resp. Shrimp 56% Salmon 50% Trout 84% Tilapia 56% Panga 65% Carp 51% Marine 57% Catfish 90%
27 Number of substances reported Species Number of products N treat N prophyl Shrimp Salmon Trout Tilapia Panga Carp Marine Catfish For several species emphasis on treating!
28 Have not generated enough information on: Pharmacodynamics Pharmacokinetics Antimicrobial interaction with the environment top coating? Fate of the antimicrobials in the environment
29 Requiere capacity building: On legislation Product: use, risks and handling
30 Insufficient aquaculture professionals A lab result is not a diagnosis Need to follow up production Need environmental data and management procedures Bacterial and parasitic diseases are often linked to a primary cause: stress Antibiotics are only tools, rarely solutions Inmediate use of antimicrobials on identification needed: do not wait for susceptibility test results If no clinical change in 48-72h, change antibiotic
31 Need to respect legislation particularly small farmers (education? inspections?) Cost of authorised products versus active compounds Good management practices: Healthy animals do not get sick!! Capacity building Need for biosecurity plans for each facility Reduce economic impact of diseases Integrated into the production practices (SOPs)
32 but what about the RELEASE into the environment of prudently used antimicrobials?
33 Little is known
34 It has been suggested that antibiotics have been produced for over 500million years (Baltz 2008) Antibiotics are naturally produced by some species of bacteria and fungi (they encode resistance to those specific antibiotics) Resistance genes existed long before we increased selection preassure Antibiotics were turned into pharmaceuticals (x00.000tns/year)-disruption of equilibrium?
35 Heberer 2002
36 Antibiotics and other pharmaceuticals are often excreted unchanged and released into municipal water sewage system B-lactams, quinolones or sulphonamides are not easily biodegradable (Al-Ahmad 1999; Kumerer 2000; Ingerslev 2000) Sorption to the sludge: Quinolones, sulphonamides and tetracyclines are sorbed: 70-90% was reextractable (30% of sludge is used as manure in Germany) Kumerer Some may be deactivated depending on the composition of the sediment A proportion of antibiotics are not broken down in STPs and are released into the environment
37 Hospitals Antibiotic concentration in hospital effluents are of the same order of magnitude as the minimum inhibitory concentrations for susceptible pathogenic bacteria (Kummerer and Henninger 2003) Ciprofloxacin up to 124ug/L (Hartman 1998) Ampicillin up to 80ug/L (Kumerer 2004) The dilutions of hospital effluents by municipal sewage will lower the concentration only moderately as it also contains antibiotics and household disinfectants
38 Verlicchi
39 Verlicchi 2010
40 Mixture of antibiotics may have a synergistic or antagonistic effect Synthetic or semisynthetic antibiotics are often more stable and not biodegradable by bacteria
41 Biodegradation in STPs: not a reliable removal of antibiotics (Kumerer 2003) Cyclosporin A: months to degrade in soil Sarafloxacin: 90% active after 80 days in soil Treatment of dewatered sludge with heat did not fully eliminate norfloxacin or ciprofloxacin (Lindberg 2007)
42 Conventional methods are innefective (biological processes, filtration, coagulation, flocculationa and sedimentation) Combination of methods might be required: advance oxidation, adsorption, membrane processes, ozonation
43 Most medical compounds are only partially metabolized by patients and are discharged into hospital sewage or municipal waste water to the STPs. The pass through the STP and are released into the environment
44 It is assumed that hospital are the most important source for the input of resistant bacteria into municipal waste water. However, consumption of antibiotics: UK: 95% community USA and Germany 75% community (Schuster 2008) Hospital in western europe contribut to 1% municipal sewage, Hospitals might not be the main source of resistant bacteria, but might be for multi-resistant bacteria
45 Human sewage comprises both antibiotic residues and antibiotic resistant bacteria (resistant determinants) Waste water treatment plants are considered reservoirs of antibiotic resistance in the environment (Gallert 2005; Ferreira da Silva 2006; Goñi-Urriza 2000; Baquero 2008; Kummerer 2009; Martinez 2009; Servais 2009) The transfer of resistant genes, as well as resistant bacteria, is favoured by the presence of antibiotics over a long period and at subtherapeutic concentrations (Salyers 1995; Ohlsen 1998)
46 Waste water treatment process has been reported to be a route for disseminating antimicrobial resistant bacteria into the environment (Kim 2007) Sewage isolates had higher antimicrobial resistance rates than clinical isolates from the same hospital (Yang 2009)
47 Assumption: No growth=death of bacteria Response to environmental factors: starvation, temperature, oxygen, light (Olivier 2000) Bactericidal treatments might induce this VBNC state (milk pasteurization, chlorination) (Olivier et al 2005) Between 90 and 99% of marine bacteria are in VBNC (Colwell; Hirashi 1998) The resuscitate to culturable state mantaining virulence and plasmids
48 Table 1. Bacteria Described to Enter the VBNC State (Oliver 2005) Aeromonas salmonicida Lactobacillus plantarum Serratia marcescens Agrobacterium tumefaciens Lactococcus lactis Shigella dysenteriae Alcaligenes eutrophus Legionella pneumophila S. flexneri Aquaspirillum sp. Listeria monocytogenes S. sonnei Burkholderia cepacia Micrococcus flavus Sinorhizobium meliloti B. pseudomallei M. luteus Streptococcus faecalis Campylobacter coli M. varians Tenacibaculum sp. C. jejuni Mycobacterium tuberculosis Vibrio anguillarum M. Smegmatis C. lari Pasteurella piscida V. campbellii Cytophaga allerginae Pseudomonas aeruginosa V. cholerae Enterobacter aerogenes P. fluorescens V. fischeri E. cloacae P. putida V. harveyi Enterococcus faecalis P. syringae V. mimicus E. hirae Ralstonia solanacearum V. natriegens E. faecium Rhizobium leguminosarum V. parahaemolyticus Escherichia coli (including EHEC) R. meliloti V. proteolytica Francisella tularensis Rhodococcus rhodochrous V. shiloi Helicobacter pylori Salmonella enteritidis V. vulnificus (types 1&2) Klebsiella aerogenes S. typhi Xanthomonas campestris K. pneumoniae S. typhimurium K. planticola
49 While it could be questionable that the presence of antibiotics in the environment leads to an increase in resistance The input of resistant bacteria from human and veterinary sources are the main contributors to resistance in the environment
50 Conclusion
51 Prudent use of antimicrobial Proper disposal of unused antimicrobials Development of new antibiotics easily biodegradable Control of the release of: Antimicrobials Resistant bacteria and resistant genes
52 Effect of subclinical doses present in the environment On antibiotic resistance development understanding Resistant genes spread in nature Different source of the different resistance found in the environment Time scale for antibiotics to inactivate in the environment
AMR in Codex Alimentarius Commission and country responsibilities
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationCODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP Adopted 2005
CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 Adopted 2005 CAC/RCP 61-2005 2 1. INTRODUCTION 2. AIMS AND OBJECTIVES 3. RESPONSIBILITIES OF THE REGULATORY AUTHORITIES
More informationOIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I
Dr Elisabeth Erlacher-Vindel Head of the Antimicrobial Resistance and Veterinary Products Department OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I 2nd
More informationCleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria
Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria This document has been developed in accordance with current applicable infection
More informationCleaning and Disinfection Protocol Vegetative Bacteria
Cleaning and Disinfection Protocol Vegetative Bacteria This document has been developed in accordance with current applicable infection control and biosecurity guidelines. It is intended for use as a guideline
More informationApproved by the Food Safety Commission on September 30, 2004
Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food
More informationDr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health
Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health Regional Workshop for National Focal Points for Veterinary Products
More informationAntimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health
Workshop for OIE national Focal Points for Veterinary Products (2 nd cycle) Vienna (Austria), 20-22 November 2012 Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial
More informationOIE standards on the use of antimicrobials and antimicrobial resistance monitoring
Caroline Planté Sub-Regional Representation in Brussels OIE standards on the use of antimicrobials and antimicrobial resistance monitoring OIE Regional Seminar on Food Safety Sofia, Bulgaria, 22-24 April
More informationUPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS
UPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS OIE global Conference on the Responsible and Prudent use of Antimicrobial Agents for Animals Paris (France), 13
More informationOIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents
OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial
More informationAntimicrobial Resistance (AMR) in Aquaculture
Antimicrobial Resistance (AMR) in Aquaculture Melba.Reantaso@fao.org AMR Side Event, COFI/SCA 9 25 October 2017, Rome, Italy http://www.fao.org/cofi/aq/90408/en/ Benefits on the use of antimicrobials Antimicrobial
More informationCollaboration between Veterinary Services and Private Sectors
Collaboration between Veterinary Services and Private Sectors The Development of Vaccines for Asian Aquaculture at Intervet Norbio Singapore SF Chang, R&D Site Manager Author/location Outline Background
More informationBeef Producers. The Judicious Use of Antimicrobials for
The Judicious Use of Antimicrobials for Beef Producers Introduction The production of safe and wholesome animal products for human consumption is a primary goal of beef producers. To achieve that goal,
More informationRecommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee
VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD
More informationOIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents
ISBN: 978-92-95108-16-5 The publication compiles a note of the OIE Director General on: the risks associated with the use of antimicrobial agents in animals worldwide; the OIE standards and guidelines
More informationANTIMICROBIAL USAGE IN AQUACULTURE
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries ANTIMICROBIAL USAGE IN AQUACULTURE Review of AMU in aquaculture based
More informationOIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools
Dr Elisabeth Erlacher-Vindel Head Science and New Technologies Department OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools 12 th OIE SEMINAR 18 th WAVLD, Sorrento (Italy),
More informationManaging AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan
Managing AMR at the Human-Animal Interface OIE Contributions to the AMR Global Action Plan 6th Asia-Pacific Workshop on Multi-Sectoral Collaboration for the Prevention and Control of Zoonoses Dr Susan
More informationCombat Antimicrobial Resistance
Dr Hirofumi Kugita OIE Regional Representation for Asia and the Pacific Overview of OIE Activities to Combat Antimicrobial Resistance Workshop on Development of Surveillance Framework for Antimicrobial
More informationAntibiotic Symposium National Institute of Animal Agriculture Atlanta, Georgia
Antibiotic Symposium National Institute of Animal Agriculture Atlanta, Georgia November 3, 2015 Robert Tauxe, MD, MPH Deputy Director, Division of Foodborne, Waterborne and Environmental Diseases National
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationCODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE
CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 INTRODUCTION 206 AIMS AND OBJECTIVES 206 RESPONSIBILITIES OF THE REGULATORY AUTHORITIES 208 Quality control of antimicrobial
More informationOIE strategy on AMR and the Prudent Use of Antimicrobials
Dr. Jocelyn Mérot OIE Sub-Regional Representation for North Africa OIE strategy on AMR and the Prudent Use of Antimicrobials 14th JPC REMESA 19-20 July 2017 Naples (Italy) The OIE Strategy on AMR and the
More informationResponsible use of antimicrobials in veterinary practice
Responsible use of antimicrobials in veterinary practice Correct antimicrobial: as little as possible, as much as necessary This document provides more information to accompany our responsible use of antimicrobials
More informationDANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme
DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP
More informationAntibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University
Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in
More informationSYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data
508 SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data Physical Properties Active Ingredient: Ethyl Alcohol 62% (70% v/v) Appearance: Clear, Colorless Solution Fragrance: Floral Form:
More informationSUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One g contains:
More informationImplementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials
Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials Dr. Sasi Jaroenpoj, D.V.M Head of Veterinary Products and AMR
More informationagenda is meeting: Codex
Original: English September 2011 REPORT OF THE MEETING OF THE OIE AD HOC GROUP ON THE RESPONSIBLE USE OFF ANTIMICROBIALS IN AQUATICC ANIMALS Paris, 8 9 September 2011 The OIE ad hoc Group on the Responsible
More informationAntimicrobial resistance: the challenges for animal health
Elisabeth Erlacher Vindel Deputy Head of the Scientific and Technical Departement World Organisation for Animal Health (OIE) Antimicrobial resistance: the challenges for animal health Rabat, 17 Feb. 2015
More informationDesign of antimicrobial susceptibility testing programmes relevant to aquaculture and aquacultural products
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Workshop 2 in cooperation with Malaysia Department of Fisheries and
More informationOIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle
Dr Elisabeth Erlacher Vindel Deputy Head of the Scientific and Technical Departement World Organisation for Animal Health (OIE) OIE Resolution and activities related to the Global Action Plan Regional
More informationAntimicrobial use in poultry: Emerging public health problem
Antimicrobial use in poultry: Emerging public health problem Eric S. Mitema, BVM, MS, PhD CPD- Diagnosis and Treatment of Poultry Diseases FVM, CAVS, 6 th. August, 2014 AMR cont Antibiotics - Natural or
More informationThe impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s)
The impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s) The evaluation of Good Veterinary Governance with the OIE Performance of Veterinary Services
More informationOIE Standards for: Animal identification and traceability Antimicrobials
OIE Standards for: Animal identification and traceability Antimicrobials OIE regional seminar on food safety Singapore, 12-14 October 2010 Yamato Atagi 1 Deputy Head, International Trade Department, OIE
More informationInternational Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
More informationAMR, Aquaculture and One Health
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationThe OIE Relevant Standards and Guidelines for Veterinary Medicinal Products
The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products REGIONAL SEMINAR OIE NATIONAL FOCAL POINTS FOR VETERINARY PRODUCTS EZULWINI, SWAZILAND, 6-8 DECEMBER 2017 Dr Mária Szabó OIE
More informationCOMMISSION NOTICE Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) Table of Contents
11.9.2015 EN Official Journal of the European Union C 299/7 COMMISSION NOTICE Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) Table of Contents Introduction... 7
More information14th Conference of the OIE Regional Commission for Africa. Arusha (Tanzania), January 2001
14th Conference of the OIE Regional Commission for Africa Arusha (Tanzania), 23-26 January 2001 Recommendation No. 1: The role of para-veterinarians and community based animal health workers in the delivery
More informationGROUP 4: ANTIMICROBIAL SUSCEPTIBILITY TESTING FOR SELECETED SPECIES
GROUP 4: ANTIMICROBIAL SUSCEPTIBILITY TESTING FOR SELECETED SPECIES CARPS-Bacterial species of importance Aeromonas sp. (A. hydrohila, A. veronii, A. sorbia, A. caviae, A. schubertii, except A. salmonicida)
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More informationEXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA
EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA PRESENTED BY DR. NATHAN K. SONGOK National Focal Point Veterinary Medicinal Products Kenya At the Regional Seminar for OIE National Focal Points
More informationThe OIE Relevant Standards and Guidelines for Vaccines
The OIE Relevant Standards and Guidelines for Vaccines GALVMED/OIE STAKEHOLDER WORKSHOP ON THE HARMONISATION OF THE REGISTRATION OF VETERINARY MEDICINAL PRODUCTS, JOHANNESBURG, SOUTH AFRICA 9-11 MAY 2017
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More information4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals
1.B1. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AMOXYCOL Soluble Powder 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Amoxicillin trihydrate 640.0
More informationruma Cattle Responsible use of antimicrobials in Cattle production GUIDELINES
ruma RESPONSIBLE USE OF MEDICINES IN AGRICULTURE ALLIANCE GUIDELINES Cattle Responsible use of antimicrobials in Cattle production RUMA guidelines for the responsible use of antimicrobials by cattle farmers
More informationThe promise of aquaculture and the challenge of antimicrobial use
The promise of aquaculture and the challenge of antimicrobial use This article is published in two parts. Part 1 identifies the promise of aquaculture and the challenge of antimicrobial use (please see
More informationFAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)
FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR) Patrick Otto, FAO, Rome On behalf of the FAO/OIE/WHO Tripartite Technical Focal Points Context 2 Global demand for food security
More informationWhat Canadian vets need to know and explain about antimicrobial resistance
What Canadian vets need to know and explain about antimicrobial resistance By John F. Prescott, MA, VetMB, PhD Major changes are underway regarding how agricultural use of antibiotics is regulated in food
More informationAntibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines
Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex III Surveillance
More informationYOU YOU WE NEED. To implement the new Antimicrobial Resistance campaign TO HANDLE ANTIMICR BIALS WITH CARE. October Veterinary Services
Veterinary Services To implement the new Antimicrobial Resistance campaign October 07 OIE-AMR-Veterinary-Services-8P-V.indd 4/0/07 3:47 To implement the new AMR communication campaign Misuse and overuse
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationFood borne diseases: the focus on Salmonella
Food borne diseases: the focus on Salmonella Prof. Jaap A. Wagenaar, DVM, PhD Dept Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, NL Central Veterinary
More informationGLOBAL PERSPECTIVES ON ANTIMICROBIAL RESISTANCE IN THE FOOD CHAIN. Sarah M Cahill, Patricia Desmarchelier, Vittorio Fattori, Andrew Cannavan
GLOBAL PERSPECTIVES ON ANTIMICROBIAL RESISTANCE IN THE FOOD CHAIN Sarah M Cahill, Patricia Desmarchelier, Vittorio Fattori, Andrew Cannavan One Health and AMR at FAO FAO calls for a One Health and food
More informationRole and responsibilities of the veterinarian in the aquatic sector The OIE perspective
Role and responsibilities of the veterinarian in the aquatic sector The OIE perspective Caring for health and welfare of fish: A critical success factor for aquaculture FVE Conference Brussels (Belgium),
More informationRisk analysis of antimicrobial use in aquaculture Peter Smith
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Risk analysis of antimicrobial use in aquaculture Peter Smith peter.smith@nuigalway.ie
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More informationOIE List of Antimicrobial Agents of Veterinary Importance and OIE Standards and Activities
Veterinary Importance and OIE Standards and Activities Consultation meeting with stakeholders - Request from the European Commission for advice on the impact on public and animal health of the use of antibiotics
More informationOIE Activities for the Containment of Antimicrobial Resistance. Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department
OIE Activities for the Containment of Antimicrobial Resistance Dr Elisabeth Erlacher-Vindel, Deputy Head of the Scientific and Technical Department Contents Introduction OIE International Standards OIE
More information2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, st February 2017.
2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, 20-21 st February 2017. Veterinary Approaches and Priorities. Indicator organisms (commensals) E. coli enterococci
More information& chicken. Antibiotic Resistance
Antibiotic Resistance & chicken Chicken Farmers of Canada (CFC) supports the judicious use of antibiotics that have been approved by the Veterinary Drugs Directorate of Health Canada, in order to ensure
More informationAdopted 39 th AMAF Meeting (28/9/2017) ASEAN GUIDELINES FOR THE PRUDENT USE OF ANTIMICROBIALS IN LIVESTOCK
Adopted 39 th AMAF Meeting (28/9/2017) ASEAN GUIDELINES FOR THE PRUDENT USE OF ANTIMICROBIALS IN LIVESTOCK ASEAN GUIDELINES FOR THE PRUDENT USE OF ANTIMICROBIALS IN LIVESTOCK Page 2 of 28 CONTENTS Introduction...
More informationThe Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University
The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin
More informationLaboratory determination of the susceptibility to antibiotics of bacteria isolated from aquatic animals Peter Smith
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Laboratory determination of the susceptibility to antibiotics of
More informationWE NEED. Veterinary Services YOU YOU. To implement the new Antimicrobial Resistance campaign TO HANDLE ANTIMICR BIALS WITH CARE
To implement the new Antimicrobial Resistance campaign Veterinary Services To implement the new AMR communication campaign Misuse and overuse of antimicrobials But can HELP, particularly as a member of
More informationSales survey of veterinary medicinal products containing antimicrobials in France in Annual report
Sales survey of veterinary medicinal products containing antimicrobials in France in 2016 Annual report October 2017 Scientific edition Sales survey of veterinary medicinal products containing antimicrobials
More informationAntibiotic resistance and the human-animal interface: Public health concerns
Antibiotic resistance and the human-animal interface: Public health concerns Antibiotic Use and Resistance Moving forward through shared stewardship National Institute for Animal Agriculture Atlanta, Georgia
More informationLiofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms
Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms Microbiology Products since 1983 Liofilchem Chromatic ESBL Selective
More informationCollection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database
Collection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database OIE Regional Workshop for OIE National Focal Points for Veterinary Products Maputo, Republic
More informationNAP on AMR: Singapore
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationRisk management of AMR in livestock sector in Japan
Risk management of AMR in livestock sector in Japan Tatsuro Sekiya Animal Products Safety Division, Food Safety and Consumer Affairs Bureau, Ministry of Agriculture, Forestry and Fisheries (MAFF) Oct.
More informationOIE Aquatic Animal Health Code and Manual of Diagnostic Tests for Aquatic Animals
Workshop for OIE National Focal Points for Aquatic Animals Lisbon, Portugal 9 11 April 2013 Gillian Mylrea OIE Aquatic Animal Health Code and Manual of Diagnostic Tests for Aquatic Animals - trade facilitating
More informationHuman Food Safety of Veterinary Drugs. Bettye K. Walters, DVM
Human Food Safety of Veterinary Drugs Bettye K. Walters, DVM Bettye.walters@fda.hhs.gov Pertinent International Resources Organization for Economic Co-Operation and Development (OECD) Understanding the
More informationFood-borne Zoonoses. Stuart A. Slorach
Food-borne Zoonoses Stuart A. Slorach OIE Conference on Evolving veterinary education for a safer world,, Paris, 12-14 14 October 2009 1 Definition For the purposes of this paper, food-borne zoonoses are
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationAntibiotic Resistance The Global Perspective
Antibiotic Resistance The Global Perspective Scott A. McEwen Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1; Email: smcewen@uoguleph.ca Introduction Antibiotics have been used
More informationJUDICIOUS USE OF ANTIMICROBIAL AGENTS
JUDICIOUS USE OF ANTIMICROBIAL AGENTS PRINCIPLES OF APPROPRIATE USE A report commissioned by the Australian Chicken Meat Federation Prepared by STEPHEN PAGE Updated September 2011 Advanced Veterinary Therapeutics
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS
European Medicines Agency Veterinary Medicines and Inspections London, 12 November 2007 EMEA/CVMP/SAGAM/383441/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Amphen 200 mg/g Granules for use in drinking water for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: Active
More informationMICROBIOLOGY of RAW MILK
MICROBIOLOGY of RAW MILK Introduction Milk and other dairy products are of superior quality and safety Milk Quality 00 29 49 69 89 99 Microbial in Raw Milk GENERAL ASPECTS Milk is a good source of nutrients
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationOIE Aquatic Animal Health Code
Dr Gillian Mylrea World Organisation for Animal Health OIE Regional training seminar for national OIE focal points for aquatic animals Dubai, UAE 27-29 September 2010 OIE Aquatic Animal Health Code -a
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationEurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment
EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment Summary Globally, pharmaceutical products are regularly administered to both livestock
More informationASEAN GOOD ANIMAL HUSBANDRY PRACTICES FOR PIGS
1 Adopted at the 40 th AMAF Meeting 11 October 2018 Ha Noi, Viet Nam ASEAN GOOD ANIMAL HUSBANDRY PRACTICES FOR PIGS ASEAN SECTORAL WORKING GROUP ON LIVESTOCK 2018 2 ASEAN GOOD ANIMAL HUSBANDRY PRACTICES
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationNew and Innovative Applications for Metals COPPER. Tony Lea International Copper Association
New and Innovative Applications for Metals COPPER Tony Lea International Copper Association SUPERBUGS 2 HOSPITAL ACQUIRED INFECTIONS Infections acquired during hospital stays kill more people than breast
More informationRole of the Veterinary Statutory Bodies (VSB) for Good Veterinary Governance.
Role of the Veterinary Statutory Bodies (VSB) for Good Veterinary Governance. OIE Global Conference on the Responsible Dr Herbert SCHNEIDER International Chairman : OIE ad hoc Group on Antimicrobial Resistance
More informationin food safety Jean-Luc ANGOT CVO France
The role of OIE and Veterinary Services in food safety Jean-Luc ANGOT CVO France «Evolving Veterinary Education for a safer World» 13th october 2009 OIE s Objectives Transparency : ensure transparency
More informationAmoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate
Annex I List of the names, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, applicant in the Member States Member State EU/EEA Applicant Name
More informationConsultation on a draft Global action plan to address antimicrobial resistance
Consultation on a draft Global action plan to address antimicrobial resistance The questionnaire is divided into four sections. The questions are broadly framed and intended to give you the opportunity
More informationFACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences
12 July 2010 FACT SHEETS On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences Denmark is a major livestock producer in Europe, and the worlds largest
More informationQuality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products
Quality of Veterinary Medicinal Products How to ensure the quality of Veterinary Medicinal Products Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products gerard.moulin@anses.fr
More information